Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 7, 2023; 29(9): 1509-1522
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1509
Table 2 Univariate and multivariate analyses of risk factors for high principal component score
Characteristics
Simple obstruction (n = 236)
Strangulated obstruction (n = 45)
Univariate
Multivariate
Univariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
OR (95%CI)
P value
Pain duration (d) 1.019 (1.002, 1.041)0.0481
Small bowel feces sign (+)/(-)0.424 (0.225, 0.783)0.00610.316 (0.158, 0.612)< 0.0001
Mural thickening (cm)2.119 (1.084, 4.375)0.03311.338 (1.098, 1.664)0.0031
Lymphocyte (109/L)0.097 (0.007, 0.665)0.03810.071 (0.003, 0.539)0.0331
Monocyte (109/L)5.472 (1.809, 17.780)0.0031
LMR (ratio)0.708 (0.541, 0.891)0.00610.656 (0.496, 0.836)0.0011
Hb (g/L)0.983 (0.969, 0.998)0.0331
PLT (109/L)1.003 (1.001, 1.007)0.0361
AST (U/L)1.075 (1.018, 1.156)0.0271
Cl (mmol/L)0.931 (0.871, 0.993)0.0311
BUN (mmol/L)1.383 (1.133, 1.786)0.00411.478 (1.169, 2.061)0.0041
PT (s)1.568 (1.141, 2.418)0.0151
APTT (s)1.109 (0.999, 1.264)0.076
DDI (mg/L)1.196 (1.006, 1.513)0.067
Creatinine (umol/L)1.034 (1.011, 1.071)0.0221